Immunotherapy: a useful strategy to help combat multidrug resistance

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• Multidrug resistance (MDR) poses a significant challenge in cancer treatment, reducing the efficacy of standard chemotherapy.
• MDR mechanisms are often distinct from those conferring resistance to immunotherapy.
• Immunotherapy offers a promising avenue to overcome MDR in various cancers.

Purpose of the Study:

• To review key concepts in cancer immunotherapy relevant to MDR-positive tumors.
• To illustrate immune principles and strategies for targeting MDR-positive cancer cells.
• To explore the potential of immunotherapy as an adjunct or standalone treatment for MDR cancers.

Main Methods:

• Review of existing literature on cancer immunotherapy and multidrug resistance.
• Analysis of different immunotherapy approaches applicable to MDR tumors.
• Discussion of rational combinations of immunotherapy with other treatment modalities.

Main Results:

• Immunotherapy resistance is generally independent of cytotoxic agent resistance mechanisms.
• Multiple immunotherapy strategies can be employed against MDR tumors, including direct immune attack and targeted delivery.
• MDR can potentially be leveraged as a target for immune-mediated destruction or drug delivery.

Conclusions:

• Cancer immunotherapy presents a viable strategy to combat multidrug resistance (MDR) in cancer.
• Various immunotherapy approaches, including direct immune attack and targeted cytotoxic delivery, can be utilized against MDR-positive tumors.
• Combining immunotherapy with other treatments may enhance efficacy against resistant cancers.